 Connection
Nidhya Navanandan to Anti-Asthmatic Agents
This is a "connection" page, showing publications Nidhya Navanandan has written about Anti-Asthmatic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.847 |
|
|
|
-
Tanverdi MS, Navanandan N. Intravenous Magnesium for Acute Asthma Exacerbations in Children: To Mag or Not to Mag. J Allergy Clin Immunol Pract. 2022 05; 10(5):1247-1248.
Score: 0.592
-
Navanandan N, Moss A, Tanverdi M, Ambroggio L, Brittan M. Corticosteroid choice and clinical outcomes for asthma exacerbations in the primary care setting. J Asthma. 2022 Feb; 59(2):333-341.
Score: 0.534
-
Navanandan N, Moran E, Smith H, Hoch H, Mistry RD. Primary care provider preferences for glucocorticoid management of acute asthma exacerbations in children. J Asthma. 2021 04; 58(4):547-553.
Score: 0.505
-
Navanandan N, Jackson ND, Hamlington KL, Everman JL, Pruesse E, Secor EA, Stewart Z, Diener K, Hardee I, Edid A, Sulbaran H, Mistry RD, Florin TA, Yoder AC, Moore CM, Szefler SJ, Liu AH, Seibold MA. Viral Determinants of Childhood Asthma Exacerbation Severity and Treatment Response. J Allergy Clin Immunol Pract. 2025 Jan; 13(1):95-104.e5.
Score: 0.175
-
Tanverdi MS, Navanandan N, Brackman S, Huber L, Leonard J, Mistry RD. Impact of a discharge prescription for dexamethasone on outcomes of children treated in the emergency department for acute asthma exacerbations. J Asthma. 2024 06; 61(6):584-593.
Score: 0.042
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|